A detailed history of Assenagon Asset Management S.A. transactions in Abbott Laboratories stock. As of the latest transaction made, Assenagon Asset Management S.A. holds 2,277,606 shares of ABT stock, worth $264 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares
2,277,606
Previous 2,401,190 5.15%
Holding current value
$264 Million
Previous $250 Million 4.07%
% of portfolio
0.54%
Previous 0.64%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 23, 2024

SELL
$100.07 - $118.13 $12.4 Million - $14.6 Million
-123,584 Reduced 5.15%
2,277,606 $260 Million
Q2 2024

Jul 18, 2024

BUY
$100.73 - $112.44 $201 Million - $224 Million
1,996,320 Added 493.08%
2,401,190 $250 Million
Q1 2024

Apr 24, 2024

SELL
$109.52 - $120.96 $1.52 Million - $1.68 Million
-13,881 Reduced 3.31%
404,870 $46 Million
Q4 2023

Jan 17, 2024

SELL
$90.19 - $110.4 $10.6 Million - $12.9 Million
-117,176 Reduced 21.86%
418,751 $46.1 Million
Q3 2023

Nov 06, 2023

BUY
$95.53 - $114.62 $13.5 Million - $16.1 Million
140,846 Added 35.65%
535,927 $51.9 Million
Q2 2023

Jul 25, 2023

SELL
$100.78 - $112.29 $83.5 Million - $93 Million
-828,307 Reduced 67.71%
395,081 $43.1 Million
Q1 2023

Apr 18, 2023

BUY
$96.86 - $114.01 $85.3 Million - $100 Million
880,729 Added 257.03%
1,223,388 $124 Million
Q4 2022

Jan 12, 2023

BUY
$95.06 - $111.52 $16.1 Million - $18.9 Million
169,551 Added 97.95%
342,659 $37.6 Million
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $21.4 Million - $24.7 Million
-220,883 Reduced 56.06%
173,108 $16.8 Million
Q2 2022

Jul 27, 2022

SELL
$102.07 - $123.37 $22.5 Million - $27.2 Million
-220,670 Reduced 35.9%
393,991 $42.8 Million
Q1 2022

Apr 25, 2022

SELL
$114.02 - $139.04 $115 Million - $140 Million
-1,006,836 Reduced 62.09%
614,661 $72.8 Million
Q4 2021

Feb 01, 2022

BUY
$115.53 - $141.46 $183 Million - $225 Million
1,587,394 Added 4654.7%
1,621,497 $228 Million
Q3 2021

Oct 19, 2021

BUY
$116.66 - $129.06 $3.52 Million - $3.89 Million
30,147 Added 762.06%
34,103 $4.03 Million
Q2 2021

Jul 15, 2021

SELL
$105.79 - $124.53 $612,735 - $721,277
-5,792 Reduced 59.42%
3,956 $459,000
Q1 2021

Apr 26, 2021

SELL
$108.84 - $128.23 $107 Million - $126 Million
-983,639 Reduced 99.02%
9,748 $1.17 Million
Q4 2020

Feb 01, 2021

BUY
$105.0 - $114.42 $104 Million - $113 Million
989,605 Added 26166.18%
993,387 $109 Million
Q3 2020

Oct 07, 2020

SELL
$91.64 - $111.29 $142 Million - $173 Million
-1,553,594 Reduced 99.76%
3,782 $412,000
Q2 2020

Jul 21, 2020

BUY
$76.57 - $98.0 $104 Million - $133 Million
1,357,624 Added 679.65%
1,557,376 $142 Million
Q1 2020

Apr 17, 2020

BUY
$62.82 - $91.86 $12.5 Million - $18.3 Million
199,752 New
199,752 $15.8 Million
Q4 2019

Jan 17, 2020

SELL
$78.51 - $87.4 $35.4 Million - $39.5 Million
-451,531 Closed
0 $0
Q3 2019

Oct 16, 2019

BUY
$81.84 - $88.74 $36.1 Million - $39.2 Million
441,631 Added 4460.92%
451,531 $37.8 Million
Q2 2019

Aug 12, 2019

SELL
$72.88 - $85.0 $3.44 Million - $4.01 Million
-47,199 Reduced 82.66%
9,900 $833,000
Q1 2019

Apr 26, 2019

BUY
$66.22 - $80.06 $2.27 Million - $2.75 Million
34,346 Added 150.95%
57,099 $4.56 Million
Q4 2018

Jan 23, 2019

SELL
$65.56 - $74.27 $8.4 Million - $9.51 Million
-128,083 Reduced 84.92%
22,753 $1.65 Million
Q3 2018

Oct 29, 2018

BUY
$60.81 - $73.36 $8.22 Million - $9.92 Million
135,201 Added 864.73%
150,836 $11.1 Million
Q2 2018

Jul 17, 2018

SELL
$57.57 - $63.54 $43.8 Million - $48.3 Million
-760,350 Reduced 97.99%
15,635 $954,000
Q1 2018

Apr 30, 2018

BUY
$56.27 - $63.62 $38.6 Million - $43.6 Million
685,213 Added 754.87%
775,985 $46.5 Million
Q4 2017

Jan 25, 2018

BUY
$53.68 - $57.47 $3.05 Million - $3.27 Million
56,868 Added 167.73%
90,772 $5.18 Million
Q3 2017

Oct 18, 2017

BUY
$48.06 - $53.64 $1.63 Million - $1.82 Million
33,904
33,904 $1.81 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $203B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Assenagon Asset Management S.A. Portfolio

Follow Assenagon Asset Management S.A. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Assenagon Asset Management S.A., based on Form 13F filings with the SEC.

News

Stay updated on Assenagon Asset Management S.A. with notifications on news.